CoChat

Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate

Open access
Winter-Vann, Ann M., Kamen, Barton A., Bergo, Martin O., Young, Stephen G., Melnyk, Stepan, James, S. Jill, Casey, Patrick J. · 2003 · Proceedings of the National Academy of Sciences
Cited by 146

The DOI matches its Crossref record.

Abstract

The antifolate methotrexate is one of the most successful drugs in cancer chemotherapy. Although its efficacy is widely attributed to a decrease in nucleotide biosynthesis ( 1 ), methotrexate is known to increase homocysteine ( 2 ), a compound associated with an elevated risk of heart disease, Alzheimer's disease ( 3 ), and neural tube defects ( 4 ). A potential mechanism for the detrimental effects of homocysteine is cellular hypomethylation from an increase in S -adenosylhomocysteine ( 5 ), an inhibitor of methyltransferases including isoprenylcysteine carboxyl methyltransferase (Icmt). Among the substrates of Icmt is the monomeric G protein Ras, a critical component of many signaling pathways that regulate cell growth and differentiation. Because carboxyl methylation of Ras is important for proper plasma membrane localization and function ( 6 ), we investigated the role of Icmt in the antiproliferative effect of methotrexate. After methotrexate treatment of DKOB8 cells, Ras methylation is decreased by almost 90%. This hypomethylation is accompanied by a mislocalization of Ras to the cytosol and a 4-fold decrease in the activation of p44 mitogen-activated protein kinase and Akt. Additionally, cells lacking Icmt are highly resistant to methotrexate. Whereas cells expressing wild-type levels of Icmt are inhibited by methotrexate, stable expression of myristoylated H-Ras, which does not require carboxyl methylation for membrane attachment ( 7 ), confers resistance to methotrexate. These results suggest that inhibition of Icmt is a critical component of the antiproliferative effect of methotrexate, expanding our understanding of this widely used drug and identifying Icmt as a target for drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1135239100

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 146

Metadata

Authors
Winter-Vann, A. M., Kamen, B. A., Bergo, M. O., Young, S. G., Melnyk, S., James, S. J., & Casey, P. J.
Venue
Proceedings of the National Academy of Sciences
Published
2003-05-15
Volume
100
Issue
11
Pages
6529-6534
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1967660811
Cited by
146
References
0
FWCI
4.50
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate. https://app.cochat.ai/papers/10.1073/pnas.1135239100
The paper
Winter-Vann, A. M., Kamen, B. A., Bergo, M. O., Young, S. G., Melnyk, S., James, S. J., & Casey, P. J. (2003). Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1135239100

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.